Pharma, device groups oppose FDA’s planned drug to device transition

May 04, 2022 On 9 August 2021, FDA published a notice announcing its implementation of a court decision in Genus Medical Technologies LLV v. FDA (Genus) and requesting public comment.  The notice states that in accordance with the Genus decision, FDA “intends to regulate products that meet both the device and drug [emphasis original] definition … Read more